USS Investment Management Ltd
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1587381
London, X0
Position in ALNY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$10,383,126
+$1,499,929 QoQ
Shares Held
34,492
+28.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#186
of 784 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $177,836,332 across 11 Biotechnology names. ALNY ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
57,903 | $53,720,666 | |
| 2 | ASND |
Ascendis Pharma A/S
|
141,010 | $37,610,187 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,893 | $24,286,619 | |
| 4 | INSM |
INSMED Inc
|
196,253 | $20,924,494 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21,035 | $13,116,163 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
34,492 | $10,383,126 | |
| 7 | RPRX |
Royalty Pharma plc
|
136,346 | $7,644,920 | |
| 8 | BNTX |
BioNTech SE
|
51,109 | $4,755,692 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,383,126 | 34,492 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,883,197 | 26,848 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $10,427,973 | 26,224 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,022,896 | 26,366 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,597,688 | 26,366 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,119,347 | 26,366 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,204,183 | 26,366 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,040,511 | 32,871 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,953,821 | 36,847 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,292,622 | 35,414 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,068,079 | 31,702 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,062,310 | 34,231 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,702,948 | 30,025 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,014,608 | 30,025 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,422,760 | 31,234 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,372,888 | 76,803 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $11,254,661 | 77,166 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $13,056,994 | 79,962 | Shares | Sole | 2022-07-18 | |
| 2021-12-31 | $12,843,989 | 75,740 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,300,469 | 75,740 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,638,568 | 56,858 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $982,400 | 6,958 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $904,331 | 6,958 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,013,084 | 6,958 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,030,549 | 6,958 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||